% | $
Quotes you view appear here for quick access.

PharmAthene, Inc. Message Board

  • brooks22 Sep 20, 2013 7:26 AM Flag

    HHS replenishes anthrax antitoxin

    HHS replenishes nation’s supply of anthrax antitoxin; orders worth $196M $GSK; $63M Cangene; $1.6M to $PIP.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Under these contracts, HHS will order approximately $196 million in antitoxin from GlaxoSmithKline. In addition, HHS will purchase materials to manufacture antitoxin. The materials include blood plasma from Cangene for approximately $63 million and a total of $1.6 million in cells from GlaxoSmithKline, PharmAthene, and Emergent. PharmAthene and Emergent have antitoxin at earlier stages of development than the GlaxoSmithKline and Cangene products.

2.89-0.02(-0.69%)Sep 23 4:02 PMEDT